摘要
目的:探讨点阵激光加卤米松乳膏联合308准分子光治疗白癜风的临床疗效。方法:选取2022年10月~2023年12月本院诊治的60例白癜风患者,根据不同治疗方案分为对照组与治疗组,每组30例。对照组仅给予308nm准分子光照射治疗,治疗组采用CO_(2)点阵激光加卤米松乳膏治疗后再予以308nm准分子光照射治疗。比较两组临床疗效、症状严重程度、不良反应发生率。结果:治疗组治疗总有效率高于对照组(P<0.05)。治疗后,两组症状严重程度均降低,且治疗组症状严重程度低于对照组(P<0.05)。治疗组不良反应发生率低于对照组(P<0.05)。结论:点阵激光加卤米松乳膏联合308准分子光治疗白癜风患者临床疗效确切,能够减轻患者症状严重程度,且安全性较高。
Objective:To investigate the clinical efficacy of dot matrix laser combined with halometasone cream and 308 excimer light in the treatment of vitiligo.Methods:60 vitiligo patients treated in our hospital from October 2022 to December 2023 were selected and included in a control group and a treatment group according to different treatment plans,with 30 patients in each group.The control group was only treated with 308nm excimer light irradiation,while the treatment group was treated with CO_(2) dot matrix laser and halometasone cream before receiving 308nm excimer light irradiation.Compare the clinical efficacy,severity of symptoms,and incidence of adverse reactions between two groups.Results:The total effective rate of the treatment group was higher than that of the control group(P<0.05).After treatment,the severity of symptoms in both groups decreased,and the severity of symptoms in the treatment group was lower than that in the control group(P<0.05).The incidence of adverse reactions in the treatment group was lower than that in the control group(P<0.05).Conclusion:The combination of dot matrix laser and halometasone cream with 308 excimer light therapy has definite clinical efficacy in treating vitiligo patients,can reduce the severity of symptoms,and has high safety.
作者
向群
徐凌宇
李明华
江思
XIANG Qun;XU Ling-yu;LI Ming-hua;JIANG Si(Department of Dermatology,Dongxiang District People’s Hospital,Fuzhou City,Jiangxi Fuzhou 331800)
出处
《中国医疗器械信息》
2025年第6期29-31,共3页
China Medical Device Information
基金
抚州市社会发展指导性科技计划项目(项目名称:点阵激光加卤米松乳膏联合308准分子光治疗白癜风临床研究,项目编号:抚科社字[2022]9号第83号)。
